Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
---|
04/12/2000 | EP0992189A1 Animals carrying 25-hydroxylated vitamin d3-24-hydroxylase gene transferred thereinto |
04/12/2000 | EP0991770A2 Prostate cancer gene |
04/12/2000 | EP0991758A1 Smad6 and uses thereof |
04/12/2000 | EP0991421A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease |
04/12/2000 | EP0991321A1 Tolerance to natural antibody antigens |
04/12/2000 | CN2372911Y Lactagogue device for animal |
04/11/2000 | US6049280 Identity and cow estrus indicator |
04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
04/11/2000 | US6048729 Animal transfected clonal cells for the expression of therapeutic products |
04/11/2000 | US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders |
04/06/2000 | WO2000018954A2 Use of pex in the treatment of metabolic bone diseases |
04/06/2000 | WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
04/06/2000 | WO2000018917A2 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION |
04/06/2000 | WO2000018908A1 Use of specific hybrid promoters for controlling tissue expression |
04/06/2000 | WO2000018902A1 Method of screening for large offspring syndrome |
04/06/2000 | WO2000018887A1 Method and apparatus for the storage of entomopathogenic nematodes |
04/06/2000 | WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
04/06/2000 | WO1999066054A3 Erythropoietin analog-human serum albumin fusion protein |
04/06/2000 | WO1999063097A3 Caspase-9 deficient animals and the use thereof |
04/06/2000 | WO1999061468A3 The induction of antibiotic peptides by lait (scd14) protein |
04/06/2000 | WO1999055730A3 Polyepitope carrier protein |
04/06/2000 | WO1999053042A3 Biological material with increased expression of endogenous complement regulatory molecules |
04/06/2000 | CA2345755A1 Method and apparatus for the storage of entomopathogenic nematodes |
04/06/2000 | CA2344104A1 Method of screening for large offspring syndrome |
04/06/2000 | CA2343939A1 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
04/06/2000 | CA2343922A1 Use of specific hybrid promoters for controlling tissue expression |
04/06/2000 | CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
04/05/2000 | EP0990041A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
04/05/2000 | EP0990032A1 Tenebrio antifreeze proteins |
04/05/2000 | EP0990030A1 Transcriptional activators with graded transactivation potential |
04/05/2000 | EP0990001A1 Processes for production of immunoglobulin a in milk |
04/05/2000 | EP0989995A2 Torsin, torsin genes, and methods of use |
04/05/2000 | EP0989859A1 Cns neuroregenerative compositions and methods of use |
04/05/2000 | EP0989805A1 Nucleic acid sequences for atp-binding cassette transporter |
04/05/2000 | EP0989802A1 Transgenic rabbits expressing cd4 and chemokine receptor |
04/05/2000 | EP0989801A2 Transgenic animals expressing human fc receptors |
04/05/2000 | EP0479866B1 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus |
04/05/2000 | CN1050968C Method and apparatus for inducing controlled stressed behavior in animals |
04/04/2000 | US6046381 Apolipoprotein E transgenic mice and assay methods |
04/04/2000 | US6046380 Dna which is modified at cryptic splice sites; for improved yield and gene therapy |
04/04/2000 | US6046317 For screening for carrier status and diagnosis of predisposition for increased serum cholesterol or low density lipoprotein cholesterol level in humans |
04/04/2000 | US6046044 Cisplatin resistance proteins |
04/04/2000 | US6046028 Polynucleotides encoding insulin homolog zins3 |
04/04/2000 | US6045997 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
04/02/2000 | CA2246664A1 Vascular specific regulatory elements contained in the desmin 5' flanking region |
03/30/2000 | WO2000017338A1 Upa/rag-2 mouse with mammalian repopulating hepatocytes for infection by hepadnaviruses |
03/30/2000 | WO2000017334A2 Analysis of ligand activated nuclear receptors i(in vivo) |
03/30/2000 | WO2000017232A2 Regulatory protein from human keratinocytes |
03/30/2000 | WO2000002584A3 Cancer treatment methods using antibodies to aminophospholipids |
03/30/2000 | WO1999053055A3 Therapeutic agent for ngf |
03/30/2000 | DE19856261C1 Detection of gamma-secretase by detection of A-beta peptide useful for determining gamma-secretase activity and for identifying inhibitors |
03/30/2000 | CA2343084A1 Upa/rag-2 mouse with mammalian repopulating hepatocytes for infection by hepadnaviruses |
03/30/2000 | CA2342957A1 Regulatory protein from human keratinocytes |
03/29/2000 | EP0989184A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding |
03/29/2000 | EP0988388A2 Ghrh expression system and methods of use |
03/29/2000 | EP0988376A2 Noey2 gene compositions and methods of use |
03/29/2000 | EP0988317A2 Aib1, a steroid receptor co-activator |
03/29/2000 | EP0988048A1 Ligand/lytic peptide compositions and methods of use |
03/28/2000 | CA2245903A1 Use of pex in the treatment of metabolic bone diseases |
03/25/2000 | CA2246702A1 Pre-testing of dna constructs by trans-somatic techniques |
03/23/2000 | WO2000015843A1 Genetic suppression therapy |
03/23/2000 | WO2000015808A1 MAMMARY GLAND TISSUE-SPECIFIC EXPRESSION SYSTEM USING $G(b)-CASEIN PROMOTER SITE OF KOREAN NATIVE GOAT |
03/23/2000 | WO2000015800A2 Rac-like genes and methods of use |
03/23/2000 | WO2000015794A1 Human cell junction pdz protein |
03/23/2000 | WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system |
03/23/2000 | WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN |
03/23/2000 | WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
03/23/2000 | WO2000015772A2 Recombinant protein production in urine |
03/23/2000 | WO2000008137A3 Transgenic animals having a modified glycoprotein v gene |
03/23/2000 | CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system |
03/23/2000 | CA2343104A1 Recombinant protein production in urine |
03/23/2000 | CA2342301A1 Human cell junction pdz protein |
03/22/2000 | EP0986951A2 Movement-responsive system for conducting tests on freely-moving animals |
03/22/2000 | EP0986640A2 Transgenic fish with tissue-specific expression |
03/22/2000 | EP0986635A1 Embryonic stem cell serum replacement |
03/22/2000 | EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals |
03/22/2000 | CN2369490Y Stereo constant temperature spray raising cage for soft-shelled turtle, tortoise, crab frog and snail |
03/22/2000 | CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells |
03/22/2000 | CN1248286A Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B) DNA and uses thereof |
03/22/2000 | CN1050498C Automatic equipment for culturing maggot by using excrement and urine |
03/21/2000 | US6040495 Hairless mouse sensitive to helicobacter pylori |
03/21/2000 | US6040429 Congenital heart disease proteins and products related thereto |
03/16/2000 | WO2000014228A1 Neutral amino acid transporter and gene thereof |
03/16/2000 | WO2000014220A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
03/16/2000 | WO2000014213A1 Highly efficient mutagenesis method with the use of psoralen derivatives |
03/16/2000 | WO2000013703A2 Methods of treating hypertension and compositions for use therein |
03/16/2000 | WO2000013702A2 Use of an angiogenic factor for the treatment of microvascular angiopathies |
03/16/2000 | WO2000006704A3 Hematopoietic cell composition for use in transplantation |
03/16/2000 | WO2000002897A3 Delta cleavage products and methods based thereon |
03/16/2000 | WO2000000500A3 Polyketides and their synthesis |
03/16/2000 | WO1999055906A3 Gene screening methods and related assays |
03/16/2000 | WO1999050404A3 Transgenic animals with inducible protein expression and methods of use |
03/16/2000 | CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
03/16/2000 | CA2341777A1 Neutral amino acid transporter and gene thereof |
03/16/2000 | CA2341762A1 Highly efficient mutagenesis method with the use of psoralen derivatives |
03/15/2000 | EP0985052A1 METHODS AND COMPOSITIONS TO IDENTIFY SWINE GENETICALLY RESISTANT TO F18 $i(E. COLI) ASSOCIATED DISEASES |
03/15/2000 | EP0985035A2 Dna methyltransferase genomic sequences and antisense oligonucleotides |
03/15/2000 | EP0434721B1 Viral nucleotide sequences |
03/15/2000 | CN1247566A Novel peptide, novel DNA, and novel antibody |
03/15/2000 | CN1247023A Production method of fowl meat |